2020
Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors.
Cooper, L., Schafer, A., Li, X., Cheng, H., Fagla, B., Shen, Z., Nowar, R., Dye, K., Anantpadma, M., Davey, R., Thatcher, G., Rong, L., & Xiong, R. (2020). Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors. 63(19). https://doi.org/10.1021/acs.jmedchem.0c01001
Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery.
Wang, L., Chen, Q., Little, N., & Lu, J. (2020). Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery. https://doi.org/10.1016/j.actbio.2020.05.026
Start low, go fast? Antipsychotic titration patterns at an inpatient psychiatric hospital.
Vadiei, N., Chien, J., Enwereji, J., Myslinski, B., & Guzman, A. (2020). Start low, go fast? Antipsychotic titration patterns at an inpatient psychiatric hospital. 10(5). https://doi.org/10.9740/mhc.2020.09.275
Survivin modulation in the antimelanoma activity of prodiginines.
Branco, P., Pontes, C., Rezende-Teixeira, P., Amengual-Rigo, P., Alves-Fernandes, D., Maria-Engler, S., da Silva, A., Pessoa, O., Jimenez, P., Mollasalehi, N., Chapman, E., Guallar, V., Machado-Neto, J., & Costa-Lotufo, L. (2020). Survivin modulation in the antimelanoma activity of prodiginines. 888. https://doi.org/10.1016/j.ejphar.2020.173465
Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3)
Madasu, C., Karri, S., Sangaraju, R., Sistla, R., & Uppuluri, M. (2020). Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3). 188.
Systematic review of longitudinal studies on chemotherapy-associated subjective cognitive impairment in cancer patients.
Kim, M., Jung, S.-O., Kim, M., & Abraham, I. (2020). Systematic review of longitudinal studies on chemotherapy-associated subjective cognitive impairment in cancer patients. 29(4). https://doi.org/10.1002/pon.5339
Targeting crucial host factors of SARS-CoV-2
Tharappel, A., Samrat, S., Li, X., & Li, X. (2020). Targeting crucial host factors of SARS-CoV-2.
TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
Gao, J., Wang, L., Gao, J., Arakawa, H., Perry, G., & Wang, L. (2020). TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer’s disease. 1866(1). https://doi.org/10.1016/j.bbadis.2019.165580
The epitranscriptomic writer ALKBH8 drives tolerance and protects mouse lungs from the environmental pollutant naphthalene.
Leonardi, A., Kovalchuk, N., Yin, L., Endres, L., Evke, S., Nevins, S., Martin, J., Dedon, P., Melendez, A., Van Winkle, L., Zhang, D., Ding, X., & Begley, T. (2020). The epitranscriptomic writer ALKBH8 drives tolerance and protects mouse lungs from the environmental pollutant naphthalene. 15(10). https://doi.org/10.1080/15592294.2020.1750213
The pharmacist's role in disaster research response.
Edwards, C., Miller, A., Cobb, P., & Erstad, B. (2020). The pharmacist’s role in disaster research response. 77(13). https://doi.org/10.1093/ajhp/zxaa093
The six Delta platform for outcome-based contracting for pharmaceuticals.
Alkhatib, N., & Abraham, I. (2020). The six Delta platform for outcome-based contracting for pharmaceuticals. 23(11). https://doi.org/10.1080/13696998.2020.1824161
2019
A co-curricular diabetes-specific elective with interprofessional students and faculty.
Fazel, M., Cooley, J., Kurdi, S., & Fazel, M. (2019). A co-curricular diabetes-specific elective with interprofessional students and faculty. 11(2). https://doi.org/10.1016/j.cptl.2018.11.006
A comparison of the pharmacologic and nonpharmacologic strategies used to manage chronic pain: Opioid users versus nonusers.
Almutairi, A., Mollon, L., Lee, J., & Slack, M. (2019). A comparison of the pharmacologic and nonpharmacologic strategies used to manage chronic pain: Opioid users versus nonusers. 59(5). https://doi.org/10.1016/j.japh.2019.06.009
A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk.
Gallo, T., Curry, S., Padilla-Jones, A., Heise, C., Ramos, K., Woosley, R., & Raschke, R. (2019). A computerized scoring system to improve assessment of heparin-induced thrombocytopenia risk. 17(2). https://doi.org/10.1111/jth.14359
A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68.
Ma, C., Hu, S., Zhang, D., Musharrafieh, R., & Wang, L. (2019). A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68. 5(11). https://doi.org/10.1021/acsinfecdis.9b00284
A STELLA simulation model for in vitro dissolution testing of respirable size particles.
Eedara, B., Tucker, I., & Das, S. (2019). A STELLA simulation model for in vitro dissolution testing of respirable size particles. 9(1). https://doi.org/10.1038/s41598-019-55164-0
Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.
Karnes, J., Miller, A., White, L., Konvinse, K., Pavlos, R., Redwood, A., Peter, J., Lehloenya, R., Mallal, S., & Phillips, E. (2019). Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. 59. https://doi.org/10.1146/annurev-pharmtox-010818-021818
Assessing the Effect of a Telepharmacist's Recommendations During an Integrated, Interprofessional Telehealth Appointment and Their Alignment with Quality Measures.
Tetuan, C., Axon, D., Bingham, J., Boesen, K., Lipsy, R., Scovis, N., Taylor, A., Warholak, T., Lott, B., & Leal, S. (2019). Assessing the Effect of a Telepharmacist’s Recommendations During an Integrated, Interprofessional Telehealth Appointment and Their Alignment with Quality Measures. 25(12). https://doi.org/10.18553/jmcp.2019.25.12.1334
Association between TDP-43 and mitochondria in inclusion body myositis.
Huntley, M., Gao, J., Termsarasab, P., Wang, L., Zeng, T., Thammongkolchai, T., Liu, P., Cohen, S., & Wang, L. (2019). Association between TDP-43 and mitochondria in inclusion body myositis. 99(7). https://doi.org/10.1038/s41374-019-0233-x
Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study
Alsuhebany, N., Alfehaid, L., Almodaimegh, H., Albekairy, A., & Alharbi, A. (2019). Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study. 5.
Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.
Haas, C., Appleman, L., Stein, M., Redlinger, M., Wilks, M., Xu, Y.- ming, Onorati, A., Kalavacharla, A., Kim, M., Zhen, C., Kadri, S., Segal, R., Gimotty, P., Davis, L., & Amaravadi, R. (2019). Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma. 25(7). https://doi.org/10.1158/1078-0432.CCR-18-2204
Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
Rangnekar, B., Momin, M., Eedara, B., Sinha, S., & Das, S. (2019). Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis. 570. https://doi.org/10.1016/j.ijpharm.2019.118689
Biologically Targeted Photo-Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion
Mi, Y., Yang, S., Bloomquist, C., Xia, M., Sun, B., Qi, Y., Wagner, K., Montgomery, S., Zhang, D., & Wang, L. (2019). Biologically Targeted Photo-Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion. 6(19).
Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures.
Patanwala, A., Radosevich, J., Meshay, I., Naderi, M., Culver, M., Lee, J., Weinberg, J., Khobrani, M., & Nix, D. (2019). Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures. https://doi.org/10.1097/MJT.0000000000001121
Center-Specific Modeling Predicts Cancer Trial Accrual More Accurately Than Investigators and Random Effects Modeling at 16 Cancer Centers.
Tate, J., Abraham, I., & Cranmer, L. (2019). Center-Specific Modeling Predicts Cancer Trial Accrual More Accurately Than Investigators and Random Effects Modeling at 16 Cancer Centers. 3. https://doi.org/10.1200/CCI.19.00005
Cisplatin protects mice from challenge of by targeting the Prp8 intein.
Li, X., Fu, P., Green, C., Liu, P., Zhang, D., Lang, Y., Chaturvedi, A., Belfort, M., Liao, G., & Li, X. (2019). Cisplatin protects mice from challenge of by targeting the Prp8 intein. 8(1). https://doi.org/10.1080/22221751.2019.1625727
Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.
Andritsos, L., Huang, P.-L., Abraham, I., Huff, K., Scrape, S., Fan, X., Alkhatib, N., Hofmeister, C., Drea, E., & McBride, A. (2019). Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization. 85. https://doi.org/10.1016/j.leukres.2019.106215
Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis.
Almutairi, A., Alkhatib, N., Martin, J., Babiker, H., Garland, L., McBride, A., & Abraham, I. (2019). Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis. 142. https://doi.org/10.1016/j.critrevonc.2019.07.004
Comparing incomparables with the wrong analytics: Anticoagulation, disability, intracranial hemorrhage, and mortality in acute cerebral vein thrombosis.
Almulhim, A., Fallatah, S., & Abraham, I. (2019). Comparing incomparables with the wrong analytics: Anticoagulation, disability, intracranial hemorrhage, and mortality in acute cerebral vein thrombosis. 178. https://doi.org/10.1016/j.thromres.2019.04.009
Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials.
Alhifany, A., Almutairi, A., Almangour, T., Shahbar, A., Abraham, I., Alessa, M., Alnezary, F., & Cheema, E. (2019). Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials. 9(11). https://doi.org/10.1136/bmjopen-2019-031145